638 related articles for article (PubMed ID: 22126246)
1. Promises and challenges of anticancer drugs that target the epigenome.
Verbrugge I; Johnstone RW; Bots M
Epigenomics; 2011 Oct; 3(5):547-65. PubMed ID: 22126246
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic cancer therapy: Proof of concept and remaining challenges.
Mund C; Lyko F
Bioessays; 2010 Nov; 32(11):949-57. PubMed ID: 21154865
[TBL] [Abstract][Full Text] [Related]
3. Small molecule modulators in epigenetics: implications in gene expression and therapeutics.
Swaminathan V; Reddy BA; Ruthrotha Selvi B; Sukanya MS; Kundu TK
Subcell Biochem; 2007; 41():397-428. PubMed ID: 17484138
[TBL] [Abstract][Full Text] [Related]
4. Histone modification therapy of cancer.
Biancotto C; Frigè G; Minucci S
Adv Genet; 2010; 70():341-86. PubMed ID: 20920755
[TBL] [Abstract][Full Text] [Related]
5. Targeting epigenetic networks with polypharmacology: a new avenue to tackle cancer.
Franci G; Miceli M; Altucci L
Epigenomics; 2010 Dec; 2(6):731-42. PubMed ID: 22122079
[TBL] [Abstract][Full Text] [Related]
6. Histone lysine methylation: an epigenetic modification?
Blackledge NP; Klose RJ
Epigenomics; 2010 Feb; 2(1):151-61. PubMed ID: 22122751
[TBL] [Abstract][Full Text] [Related]
7. Epi-drugs to fight cancer: from chemistry to cancer treatment, the road ahead.
Mai A; Altucci L
Int J Biochem Cell Biol; 2009 Jan; 41(1):199-213. PubMed ID: 18790076
[TBL] [Abstract][Full Text] [Related]
8. Will DNA methylation inhibitors work in solid tumors? A review of the clinical experience with azacitidine and decitabine in solid tumors.
Cowan LA; Talwar S; Yang AS
Epigenomics; 2010 Feb; 2(1):71-86. PubMed ID: 22122748
[TBL] [Abstract][Full Text] [Related]
9. Approaches to target the genome and its epigenome in cancer.
Chapman-Rothe N; Brown R
Future Med Chem; 2009 Nov; 1(8):1481-95. PubMed ID: 21426061
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic regulation of HIV-1 transcription.
Tripathy MK; Abbas W; Herbein G
Epigenomics; 2011 Aug; 3(4):487-502. PubMed ID: 22126207
[TBL] [Abstract][Full Text] [Related]
11. Global epigenetic profiling in bladder cancer.
Dudziec E; Goepel JR; Catto JW
Epigenomics; 2011 Feb; 3(1):35-45. PubMed ID: 22126151
[TBL] [Abstract][Full Text] [Related]
12. Screening for compounds that modulate epigenetic regulation of the transcriptome: an overview.
Eglen RM; Reisine T
J Biomol Screen; 2011 Dec; 16(10):1137-52. PubMed ID: 22002420
[TBL] [Abstract][Full Text] [Related]
13. Unraveling the epigenetic code of cancer for therapy.
Smith LT; Otterson GA; Plass C
Trends Genet; 2007 Sep; 23(9):449-56. PubMed ID: 17681396
[TBL] [Abstract][Full Text] [Related]
14. Epigenomics in respiratory epithelium carcinogenesis: prevention and therapeutic challenges.
Karamouzis MV; Konstantinopoulos PA; Papavassiliou AG
Cancer Treat Rev; 2007 May; 33(3):284-8. PubMed ID: 17367937
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
[TBL] [Abstract][Full Text] [Related]
16. The future therapeutic potential of histone demethylases: A critical analysis.
Natoli G; Testa G; De Santa F
Curr Opin Drug Discov Devel; 2009 Sep; 12(5):607-15. PubMed ID: 19736620
[TBL] [Abstract][Full Text] [Related]
17. Targeting the histone orthography of cancer: drugs for writers, erasers and readers.
Simó-Riudalbas L; Esteller M
Br J Pharmacol; 2015 Jun; 172(11):2716-32. PubMed ID: 25039449
[TBL] [Abstract][Full Text] [Related]
18. Histone deacetylase inhibitors: apoptotic effects and clinical implications (Review).
Emanuele S; Lauricella M; Tesoriere G
Int J Oncol; 2008 Oct; 33(4):637-46. PubMed ID: 18813776
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic targets in hematological malignancies: combination therapies with HDACis and demethylating agents.
Bishton M; Kenealy M; Johnstone R; Rasheed W; Prince HM
Expert Rev Anticancer Ther; 2007 Oct; 7(10):1439-49. PubMed ID: 17944568
[TBL] [Abstract][Full Text] [Related]
20. Chromatin: a key player in complex gene regulation and future cancer therapeutics.
Roukos DH
Epigenomics; 2011 Aug; 3(4):395-9. PubMed ID: 22126199
[No Abstract] [Full Text] [Related]
[Next] [New Search]
